# ImpactLife – FDA Inspection, Jul 3, 2025

Source: https://www.keypedia.com/records/fda_inspections/impactlife/8f57693f-a1d8-4fed-9d81-69de6e1fbea1
Source feed: FDA_Inspections

> FDA inspection 1274630 of ImpactLife, July 03, 2025. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 606. Form 483 issued. 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1274630
- Company Name: ImpactLife
- Inspection Date: 2025-07-03
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Chicago District Office
- Citation Count: 1

## Related Documents

- FDA Inspection 1106877 - 2019-09-12
- [FDA Inspection 1026192 - 2017-07-18](https://www.keypedia.com/records/fda_inspections/impactlife/a78a55a8-8e4d-4695-8d0d-bd3e9d3b1521)
- FDA Inspection 921394 - 2015-03-26
- [FDA Inspection 828694 - 2013-05-01](https://www.keypedia.com/records/fda_inspections/impactlife/57b874e2-edda-4f81-bab3-ae224e280e7d)
- FDA Inspection 700491 - 2010-12-07

## Related Officers

- [FDA Personnel](https://www.keypedia.com/people/zoey-a-trombley/cb7ac4dd-bc47-4b51-8fef-a485b122c921)

Company: https://www.keypedia.com/companies/impactlife/4a069fdf-ff53-49b2-b830-1f43d195d28e

Office: https://www.keypedia.com/offices/chicago-district-office/a510300b-0eaf-4a33-90b5-231d95977669
